Vasbinder, Melissa M.; Alimzhanov, Marat; Augustin, Martin; Bebernitz, Geraldine; Bell, Kirsten; Chuaqui, Claudio; Deegan, Tracy; Ferguson, Andrew D.; Goodwin, Kelly; Huszar, Dennis; Kawatkar, Aarti; Kawatkar, Sameer; Read, Jon; Shi, Jie; Steinbacher, Stefan; Steuber, Holger; Su, Qibin; Toader, Dorin; Wang, Haixia; Woessner, Richard; Wu, Allan; Ye, Minwei; Zinda, Michael published the artcile< Identification of azabenzimidazoles as potent JAK1 selective inhibitors>, Recommanded Product: 4,5-Dichloropyridin-2-amine, the main research area is azabenzimidazoles screening JAK1 selective inhibitor STAT3; Azabenzimidazoles; JAK selectivity; JAK1; JAK1 inhibitors.
We have identified a class of azabenzimidazoles as potent and selective JAK1 inhibitors. Investigations into the SAR are presented along with the structural features required to achieve selectivity for JAK1 vs. other JAK family members. An example from the series demonstrated highly selective inhibition of JAK1 vs. JAK2 and JAK3, along with inhibition of pSTAT3 in vivo, enabling it to serve as a JAK1 selective tool compound to further probe the biol. of JAK1 selective inhibitors.
Bioorganic & Medicinal Chemistry Letters published new progress about Drug screening. 188577-68-6 belongs to class pyridine-derivatives, and the molecular formula is C5H4Cl2N2, Recommanded Product: 4,5-Dichloropyridin-2-amine.